je.st
news
Tag: patients
FDA OKs breakthrough cholesterol drug for high-risk patients
2015-07-24 21:19:33| Biotech - Topix.net
" The Food and Drug Administration says it has approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. The drug from Sanofi and Regeneron Pharmaceuticals Inc. offers an important new option for millions of patients at high risk of heart disease.
Tags: drug
patients
cholesterol
breakthrough
Alzheimer's Trials Offer Few Answers for Investors, Patients
2015-07-22 22:46:29| Agriculture - Topix.net
Trial results released Wednesday on two experimental drugs didn't deliver a definitive answer as to whether the medications will work. Eli Lilly & Co.'
Tags: offer
answers
patients
investors
European Commission Approves Mercks Anti-PD-1 Therapy, KEYTRUDA (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma
2015-07-22 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYTRUDA Demonstrated Superior Survival versus Ipilimumab in a Phase 3 Clinical Trial KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the European Commission has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma in adults. The European Commission approval of KEYTRUDA is based on data from three clinical studies conducted in more than 1,500 first-line and previously-treated patients with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orAn Phan, (908) 255-6325orInvestor:Joseph Romanelli, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
advanced
european
commission
Leading Danish Cancer Center First in Europe to Use Varian's Calypso Transponders for Liver Cancer Patients
2015-07-20 12:31:12| Industrial Newsroom - All News for Today
AARHUS, Denmark Aarhus University Hospital in Denmark has treated two liver cancer patients with stereotactic body radiotherapy (SBRT) using Calypso 'GPS for the Body' transponders from Varian Medical Systems (NYSE: VAR) for real-time monitoring during the treatment. A 77-year-old man and a woman, aged 76, both...
Tags: center
europe
leading
cancer
NuShield and LC Technologies Team up to Help Patients Communicate Using Eye Tracking Technology on Tablets
2015-07-14 12:31:14| Industrial Newsroom - All News for Today
NEWTOWN, Pa. and FAIRFAX, Va. - LC Technologies, an industry-leading developer of eye tracking software and NuShield, Inc., an industry leader in screen protector and glare-elimination technology, teamed up to bring communication mobility to disabled patients who cannot communicate through speech or hand...
Tags: on
technology
team
eye
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »